title: Parkin is protective against proteotoxic stress in a transgenic zebrafish model.
abstract: BACKGROUND
  Mutations in the gene encoding the E3 ubiquitin ligase parkin (PARK2) are responsible for the majority of autosomal recessive parkinsonism. Similarly to other knockout mouse models of PD-associated genes, parkin knockout mice do not show a substantial neuropathological or behavioral phenotype, while loss of parkin in Drosophila melanogaster leads to a severe phenotype, including reduced lifespan, apoptotic flight muscle degeneration and male sterility. In order to study the function of parkin in more detail and to address possible differences in its role in different species, we chose Danio rerio as a different vertebrate model system.
  
  
  RESULTS
  We first cloned zebrafish parkin to compare its biochemical and functional aspects with that of human parkin. By using an antisense knockdown strategy we generated a zebrafish model of parkin deficiency (knockdown efficiency between 50% and 60%) and found that the transient knockdown of parkin does not cause morphological or behavioral alterations. Specifically, we did not observe a loss of dopaminergic neurons in parkin-deficient zebrafish. In addition, we established transgenic zebrafish lines stably expressing parkin by using a Gal4/UAS-based bidirectional expression system. While parkin-deficient zebrafish are more vulnerable to proteotoxicity, increased parkin expression protected transgenic zebrafish from cell death induced by proteotoxic stress.
  
  
  CONCLUSIONS
  Similarly to human parkin, zebrafish parkin is a stress-responsive protein which protects cells from stress-induced cell death. Our transgenic zebrafish model is a novel tool to characterize the protective capacity of parkin in vivo.
authors.affiliation: Neurobiochemistry, Adolf-Butenandt-Institute, Ludwig Maximilians University, Munich, Germany.
authors.forename: Mareike E
authors.initials: ME
authors.lastname: Fett
authors.forename: Anna
authors.initials: A
authors.lastname: Pilsl
authors.forename: Dominik
authors.initials: D
authors.lastname: Paquet
authors.forename: Frauke
authors.initials: F
authors.lastname: van Bebber
authors.forename: Christian
authors.initials: C
authors.lastname: Haass
authors.forename: Jörg
authors.initials: J
authors.lastname: Tatzelt
authors.forename: Bettina
authors.initials: B
authors.lastname: Schmid
authors.forename: Konstanze F
authors.initials: KF
authors.lastname: Winklhofer
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D017209:Apoptosis / Q000235:genetics / Q000502:physiology; D015153:Blotting, Western; D002460:Cell Line; D045744:Cell Line, Tumor; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006367:HeLa Cells; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D053078:Membrane Potential, Mitochondrial / Q000235:genetics / Q000502:physiology; D009474:Neurons / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*; D015027:Zebrafish / Q000235:genetics / Q000378:metabolism*
chemical_list: D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D004298:Dopamine